CME Amsterdam B.V. receives approval from Dutch Minister of Finance
CME Group will transition BrokerTec’s European Government Bond and European Repo businesses and on-MTF FX forwards and swaps to CME Amsterdam B.V.
International derivatives marketplace CME Group Inc (NASDAQ:CME) is actively preparing for all possible outcomes of the UK’s withdrawal from the European Union. The Group has just marked a significant achievement in this respect.
CME today announces that its new legal entity CME Amsterdam B.V. has secured approval from the Dutch Minister of Finance.
The establishment of the new Amsterdam-based entity will ensure that CME Group’s BrokerTec and EBS venues and CME Regulatory Reporting services (formerly known as NEX Regulatory Reporting) can continue to service their European Union clients, regardless of the outcome of the UK’s withdrawal from the EU.
CME Group will transition the following businesses to CME Amsterdam B.V. – BrokerTec’s European Government Bond and European Repo businesses (under a new Regulated Market licence) and on-MTF FX forwards and swaps (under a new MTF licence), to maintain a single pool of liquidity. BrokerTec’s UK Gilts and Gilt Repo businesses and all other EBS businesses, will continue to operate with no change.
Furthermore, CME Group will transition the CME Regulatory Reporting Approved Publication Arrangement (APA) and Approved Reporting Mechanism (ARM) trade and transaction reporting services for EU27 clients to CME Amsterdam B.V., in order to minimise disruption and assist clients in meeting their MiFID II obligations.
CME Amsterdam B.V. will operate alongside Abide Financial DRSP Limited (AFDL), which is authorised as an ARM and APA by the UK FCA and will continue to provide these services to UK clients.
CME Amsterdam B.V. is set to commence operations from March 18, 2019.
